Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
Cui C, Lian B, Zhang X, Wu D, Li K, Si L, Yang Y, Tian H, Zhou L, Chi Z, Sheng X, Kong Y, Mao L, Wang X, Bai X, Yan X, Li S, Dai J, Tang B, Wei X, Gershenwald JE, Balch CM, Guo J. Cui C, et al. Among authors: wu d. Ann Surg Oncol. 2022 Aug;29(8):5221-5234. doi: 10.1245/s10434-022-11670-6. Epub 2022 Apr 9. Ann Surg Oncol. 2022. PMID: 35397739
Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X, Wu D, Chen Y, Li H, Zhang R, Yao H, Chi Z, Cui C, Bai X, Mao L, Qi Z, Li K, Lan S, Chen L, Guo R, Yao X, Lian B, Kong Y, Dai J, Tang B, Wang X, Guo J, Si L. Wei X, et al. Among authors: wu d. Br J Dermatol. 2022 Jun;186(6):977-987. doi: 10.1111/bjd.21026. Epub 2022 Mar 25. Br J Dermatol. 2022. PMID: 35042273 Free PMC article.
Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
Wei X, Chen Y, Yao H, Wu D, Li H, Zhang R, Chi Z, Cui C, Bai X, Mao L, Qi Z, Li K, Lan S, Chen L, Guo R, Yao X, Lian B, Kong Y, Dai J, Tang B, Wang X, Gershenwald JE, Balch CM, Guo J, Si L. Wei X, et al. Among authors: wu d. J Am Acad Dermatol. 2022 Dec;87(6):1287-1294. doi: 10.1016/j.jaad.2022.08.052. Epub 2022 Sep 6. J Am Acad Dermatol. 2022. PMID: 36075285 Free article.
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
Cui C, Chen Y, Luo Z, Zou Z, Jiang Y, Pan H, Fan Q, Zhao J, Xu Q, Jiang R, Wang X, Ma T, Guo Z, Si L, Chi Z, Sheng X, Dou Y, Tan Q, Wu D, Guo J. Cui C, et al. Among authors: wu d. BMC Cancer. 2023 Feb 6;23(1):121. doi: 10.1186/s12885-022-10473-y. BMC Cancer. 2023. PMID: 36747118 Free PMC article. Clinical Trial.
A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non-small-cell lung cancer who have progressed after anti-PD-1/L1 therapy.
Zhao Y, Chen X, Yao J, Long J, Mao Y, Wu D, Zang A, Zhao J, Liu Z, Meng R, Chen Y, Luo Y, Guo Q, Li L, Cui J. Zhao Y, et al. Among authors: wu d. Cancer Med. 2024 Feb;13(3):e6855. doi: 10.1002/cam4.6855. Epub 2024 Jan 12. Cancer Med. 2024. PMID: 38214075 Free PMC article. Clinical Trial.
25,372 results
You have reached the last available page of results. Please see the User Guide for more information.